Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.550
-0.020 (-0.78%)
At close: Apr 4, 2025, 4:00 PM
2.561
+0.011 (0.44%)
After-hours: Apr 4, 2025, 7:55 PM EDT
Vivos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 6.30, with a low estimate of 6.00 and a high estimate of 6.60. The average target predicts an increase of 147.06% from the current stock price of 2.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
The average analyst rating for Vivos Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +158.82% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $8.25 → $6 | Strong Buy | Maintains | $8.25 → $6 | +135.29% | Nov 19, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.4 → $6.6 | Strong Buy | Maintains | $6.4 → $6.6 | +158.82% | Aug 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +2,350.98% | Jan 17, 2023 |
| Roth Capital | Roth Capital | Strong Buy Maintains $275 → $250 | Strong Buy | Maintains | $275 → $250 | +9,703.92% | Aug 13, 2021 |
Financial Forecast
Revenue This Year
15.51M
from 13.80M
Increased by 12.35%
Revenue Next Year
19.54M
from 15.51M
Increased by 26.02%
EPS This Year
-2.30
from -11.14
EPS Next Year
-1.09
from -2.30
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 16.0M | 21.0M |
| Avg | 15.5M | 19.5M |
| Low | 14.9M | 17.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 15.7% | 35.5% |
| Avg | 12.4% | 26.0% |
| Low | 7.9% | 15.7% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -2.36 | -0.74 |
| Avg | -2.30 | -1.09 |
| Low | -2.21 | -1.40 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.